Aclaris Therapeutics, Inc. (ACRS) financial statements (2021 and earlier)

Company profile

Business Address 640 LEE ROAD
WAYNE, PA 19087
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:547516820917492
Cash and cash equivalents22  203010
Short-term investments323911117410775
Other undisclosed cash, cash equivalents, and short-term investments(0)365715377
Receivables1150  
Inventory, net of allowances, customer advances and progress billings  1   
Inventory  1   
Deferred costs    0 
Disposal group, including discontinued operation 5    
Assets held-for-sale, not part of disposal group     0
Other undisclosed current assets336(9)(36)(6)
Total current assets:578417920013987
Noncurrent Assets
Property, plant and equipment224200
Long-term investments and receivables   15377
Long-term investments   15377
Intangible assets, net (including goodwill)779126  
Goodwill  1919  
Intangible assets, net (excluding goodwill)77737  
Other noncurrent assets550000
Other undisclosed noncurrent assets    0 
Total noncurrent assets:13149643388
TOTAL ASSETS:719827624417694
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1118271362
Accounts payable51015831
Accrued liabilities6813531
Disposal group, including discontinued operation34    
Other liabilities11    
Total current liabilities:1522271362
Noncurrent Liabilities
Long-term debt and lease obligation3     
Operating lease, liability3 
Liabilities, other than long-term debt8635  
Deferred tax liabilities, net11  
Deferred income tax liabilities01
Other liabilities3421  
Business combination, contingent consideration, liability4214  
Other undisclosed noncurrent liabilities8 30 0 
Total noncurrent liabilities:1863350 
Total liabilities:3328601872
Stockholders' equity
Stockholders' equity attributable to parent387021522516993
Additional paid in capital542524507385261136
Accumulated other comprehensive loss(0)(0)(0)(0)(0)(0)
Accumulated deficit(505)(454)(292)(159)(91)(43)
Total stockholders' equity:387021522516993
TOTAL LIABILITIES AND EQUITY:719827624417694

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues64102  
Revenue, net2  
Cost of revenue(5)(4)(7)(1)  
Gross profit:1030  
Operating expenses(52)(111)(139)(73)(49)(21)
Operating loss:(51)(111)(135)(72)(49)(21)
Nonoperating income (expense)(0)(2)3200
Investment income, nonoperating     0
Other nonoperating income (expense)(0)(2)320 
Interest and debt expense(0)(0)    
Other undisclosed income from continuing operations before equity method investments, income taxes0     
Loss from continuing operations before equity method investments, income taxes:(51)(114)(133)(70)(48)(21)
Other undisclosed loss from continuing operations before income taxes(0)(48)    
Loss from continuing operations before income taxes:(51)(161)(133)(70)(48)(21)
Income tax benefit0  2  
Loss from continuing operations:(51)(161)(133)(69)(48)(21)
Income from discontinued operations0     
Net loss attributable to parent:(51)(161)(133)(69)(48)(21)
Preferred stock dividends and other adjustments     (3)
Net loss available to common stockholders, diluted:(51)(161)(133)(69)(48)(23)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(51)(161)(133)(69)(48)(21)
Other comprehensive income (loss)(0)000(0)(0)
Comprehensive loss, net of tax, attributable to parent:(51)(161)(133)(69)(48)(21)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: